MTBC Inc
Change company Symbol lookup
Select an option...
MTBCP MTBC Inc
MTBC MTBC Inc
GSBD Goldman Sachs BDC Inc
YUMA Yuma Energy Inc
BAC Bank of America Corp
$GSPIN S&P INTERNET&CAT
LJPC La Jolla Pharmaceutical Co
NBR Nabors Industries Ltd
GPRO GoPro Inc
DDD 3D Systems Corp
Go

Health Care : Health Care Technology | Small Cap BlendCompany profile

MTBC Inc., formerly Medical Transcription Billing, Corp., is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company's offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform. PracticePro includes practice management software and related tools, which facilitate the day-to-day operation of a medical practice; electronic health records (EHR), which allow its customers to qualify for government incentives; revenue cycle management (RCM) services, which include medical billing, analytics and related services, and mobile Health solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The Company offers a clearinghouse service, which allows clients to track claim status.

Closing Price
$26.60
Day's Change
-0.0891 (-0.33%)
Bid
--
Ask
--
B/A Size
--
Day's High
26.69
Day's Low
26.58
Volume
(Heavy Day)
Volume:
13,756

10-day average volume:
11,422
13,756

ADTN CLASS ACTION DEADLINE: Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against ADTRAN, Inc.

3:11 pm ET October 18, 2019 (BusinessWire) Print

Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of ADTRAN, Inc. ("ADTRAN" or the "Company") (NASDAQ: ADTN) between February 28, 2019 and October 9, 2019, inclusive (the "Class Period"). The lawsuit filed in the United States District Court for the Southern District of New York alleges violations of the Securities Exchange Act of 1934.

If you purchased ADTRAN securities, and/or would like to discuss your legal rights and options please visit ADTRAN Shareholder Class Action or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that there were material weaknesses in the Company's internal control over financial reporting; (2) that, as a result, certain E&O reserves had been improperly reported; (3) that, as a result, the Company's financial results for certain periods were misstated; (4) that there would be a pause in shipments to the Company's Latin American customer; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

On July 17, 2019, the Company announced "preliminary" earnings for second quarter 2019 due to its ongoing assessment of the reasonableness of its current and previously reported excess and obsolete inventory reserves ("E&O reserves"). On this news, the Company's share price fell $3.69 per share, over 23%, to close at $12.13 per share on July 18, 2019, thereby injuring investors.

Then, on October 9, 2019, after-market, the Company announced that its "revenue this quarter has been significantly impacted by a pause in shipments to a Tier 1 customer in Latin America and the continued slowdown in the spending at an international Tier 1 customer." On this news, the Company's share price fell $2.10 per share, over 19%, to close at $8.81 per share on October 10, 2019, thereby injuring investors further.

If you purchased ADTRAN securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/adtraninc-adtn-shareholder-class-action-lawsuit-stock-fraud-204/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

If you wish to serve as lead plaintiff, you must move the Court no later than December 16, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. (C) 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191018005548/en/

SOURCE: Bernstein Liebhard LLP">

Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com 
(877) 779-1414
MGuarnero@bernlieb.com

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.